Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:30 PM
Ignite Modification Date: 2025-12-25 @ 4:01 PM
NCT ID: NCT02948257
Description: None
Frequency Threshold: 0
Time Frame: 30 days
Study: NCT02948257
Study Brief: VASCADE ANTEGRADE-PVD Post-Market Registry
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
VASCADE VCS The Cardiva VASCADETM Vascular Closure System (VCS) was used to seal femoral arterial access sites at the completion of ipsilateral peripheral interventional procedures performed through 5-7 Fr introducer sheaths via an antegrade approach. 0 None 2 52 11 52 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Chronic osteomyelitis of ankle/foot NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Anemia NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Sepsis NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Acute Kidney Injury NON_SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Access site arterial re-bleeding after initial hemostasis NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Residual hematoma < 6 cm NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Tissue tract oozing - prolonged NON_SYSTEMATIC_ASSESSMENT Infections and infestations None View
Pseudoaneurysm not requiring repair NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Bruising NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Groin pain NON_SYSTEMATIC_ASSESSMENT Surgical and medical procedures None View
Angina NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Worsening PVD NON_SYSTEMATIC_ASSESSMENT Vascular disorders None View
Hypotension NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Mechanical Fall NON_SYSTEMATIC_ASSESSMENT General disorders None View